Cargando…
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
BACKGROUND: A series of evidence revealed that body mass index was an important confounding factor in the research of uric acid and ischemic heart disease/hypertension. The objective of this study was to investigate whether obesity status can modify the association between serum uric acid and the se...
Autores principales: | Zhou, Mimi, Yang, Nan, Xing, Xin, Chang, Danyan, Li, Juan, Deng, Jiang, Chen, Yi, Hu, Chunhua, Zhang, Rou, Lu, Xiaolan, Zhao, Yingren, He, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845112/ https://www.ncbi.nlm.nih.gov/pubmed/33509116 http://dx.doi.org/10.1186/s12876-021-01615-w |
Ejemplares similares
-
The prevalence, comorbidities, influencing factors, and identifying factors of non-obese fatty liver disease
por: Gao, Ning, et al.
Publicado: (2022) -
Are the polyol pathway and hyperuricemia partners in the development of non‐alcoholic fatty liver disease in diabetes?
por: Hotta, Nigishi, et al.
Publicado: (2020) -
Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver
por: Golmohammadi, Sima, et al.
Publicado: (2020) -
Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B
por: Li, Juan, et al.
Publicado: (2021) -
Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults
por: Shi, Ameng, et al.
Publicado: (2023)